| Name | erythropoietin |
|---|---|
| Synonyms | EP; EPO; Epoetin; Erythropoietin; Erythropoietin precursor; Epoetins; Erythropoietins; Erythropoietin precursors |
| Name | sulfoxide |
|---|---|
| CAS | 5-[2-(octylsulfinyl)propyl]-1,3-benzodioxole |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 19347245 | Scher W, Jing Y, Lu M, Bishop DF, Scher BM: Sequences of polycythemia-type Friend spleen focus-forming virus in clone-745-derived mouse erythroleukemia cells. Arch Virol. 2009;154(5):895-8. Epub 2009 Apr 4. Mice infected with the original Friend virus isolates were anemic, so sub-lines derived from these mice should be erythropoietin-dependent for induction of erythrodifferentiation. |
3(0,0,0,3) | Details |
| 18661870 | Labrenz SR, Calmann MA, Heavner GA, Tolman G: The oxidation of -54 of epoetinum alfa does not affect molecular structure or stability, but does decrease biological activity. PDA J Pharm Sci Technol. 2008 May-Jun;62(3):211-23. Erythropoietin therapy is used to treat severe anemia in renal failure and chemotherapy patients. We have observed partial and full chemical oxidation of -54 to -54 sulfoxide, accomplished using tert-Butylhydroperoxide and peroxide, respectively. |
2(0,0,0,2) | Details |
| 20008515 | DeNiro M, Al-Halafi A, Al-Mohanna FH, Alsmadi O, Al-Mohanna FA: Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of -induced retinopathy. Mol Pharmacol. 2010 Mar;77(3):348-67. Epub 2009 Dec 14. Furthermore, YC-1 down-regulated VEGF, erythropoietin, endothelin-1, matrix metalloproteinase-9, and iNOS message and protein levels. |
1(0,0,0,1) | Details |
| 19327822 | Murua A, Orive G, Hernandez RM, Pedraz JL: Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts. Biomaterials. 2009 Jul;30(20):3495-501. Epub 2009 Mar 27. In the present paper, alginate-poly-l--alginate (APA) microcapsules containing erythropoietin (Epo)-secreting C (2) C (12) myoblasts were elaborated, characterized and tested both in vitro and in vivo. |
1(0,0,0,1) | Details |
| 19659677 | Migliaccio G, Sanchez M, Leblanc A, Masiello F, Tirelli V, Migliaccio AR, Najfeld V, Whitsett C: Long-term storage does not alter functionality of in vitro generated human erythroblasts: implications for ex vivo generated erythroid transfusion products. Transfusion. 2009 Dec;49(12):2668-79. Epub 2009 Jul 29. STUDY DESIGN AND METHODS: Using mononuclear cells from four adult blood donors, erythroblasts were generated ex vivo in expansion cultures supplemented with stem cell factor, interleukin-3, erythropoietin (EPO), dexamethasone, and |
1(0,0,0,1) | Details |
| 18336085 | Binder C, Lafayette A, Archibeque I, Sun Y, Plewa C, Sinclair A, Emkey R: Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaign. Assay Drug Dev Technol. 2008 Feb;6(1):27-37. STAT5 is phosphorylated by several JAKs, including Jak3, Jak2, and Tyk2, in response to interleukin-2, erythropoietin (EPO), and interleukin-22, respectively. |
1(0,0,0,1) | Details |